Last Updated: 19 Sep 2024
Executive Summary
Paragon 28 Inc. (FNA) is a medical device company that designs, develops, distributes, and sells foot and ankle surgical systems. The company has a market capitalization of $581.45 million and its latest stock price is $6.96. Paragon 28 Inc. is facing challenges, including negative earnings, low profit margins, and a high debt-to-equity ratio. However, the company has a strong analyst rating, with three strong buy ratings and four buy ratings. The company's revenue is expected to grow in the future, and its stock price is expected to increase.
Company Overview
Paragon 28 Inc. is headquartered in Englewood, Colorado. The company was founded in 1994 and has been publicly traded since 2004. Paragon 28 Inc. has a workforce of approximately 300 employees. The company's products are sold in the United States and internationally.
Fundamental Analysis
Paragon 28 Inc.'s financial performance has been mixed in recent years. The company has reported negative earnings in each of the past three years. In 2023, the company reported a net loss of $24.04 million, or $0.66 per share. Paragon 28 Inc.'s revenue has grown in recent years, but the company's profit margins have declined. In 2023, the company's gross profit margin was 23.3%, and its operating margin was 17.6%. Paragon 28 Inc.'s balance sheet is weak. The company has a high debt-to-equity ratio of 1.5. The company's cash flow from operations has been negative in each of the past three years.
Technical Analysis
Paragon 28 Inc.'s stock price has been trending down in recent months. The stock price is currently below its 50-day and 200-day moving averages. The stock price is also below its 52-week low of $5.55. The technical analysis suggests that Paragon 28 Inc.'s stock price is likely to continue to decline in the short term.
Short Term Outlook
Paragon 28 Inc.'s short-term outlook is negative. The company is facing challenges, including negative earnings, low profit margins, and a high debt-to-equity ratio. The technical analysis suggests that the stock price is likely to continue to decline in the short term.
Long Term Outlook
Paragon 28 Inc.'s long-term outlook is more positive. The company's revenue is expected to grow in the future, and its stock price is expected to increase. The company's strong analyst rating is also a positive sign.
Analyst Recommendations
Analysts are bullish on Paragon 28 Inc. Three analysts have a strong buy rating on the stock, and four analysts have a buy rating. The average analyst target price is $14.4.
